BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35433413)

  • 1. Inter-Observer and Intra-Observer Variability in Gross Tumor Volume Delineation of Primary Esophageal Carcinomas Based on Different Combinations of Diagnostic Multimodal Images.
    Li F; Li Y; Wang X; Zhang Y; Liu X; Liu S; Wang W; Wang J; Guo Y; Xu M; Li J
    Front Oncol; 2022; 12():817413. PubMed ID: 35433413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced inter-observer and intra-observer delineation variation in esophageal cancer radiotherapy by use of fiducial markers.
    Machiels M; Jin P; van Hooft JE; Gurney-Champion OJ; Jelvehgaran P; Geijsen ED; Jeene PM; Willemijn Kolff M; Oppedijk V; Rasch CRN; van Herk MB; Alderliesten T; Hulshof MCCM
    Acta Oncol; 2019 Jun; 58(6):943-950. PubMed ID: 30905243
    [No Abstract]   [Full Text] [Related]  

  • 3. Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study.
    Lütgendorf-Caucig C; Fotina I; Stock M; Pötter R; Goldner G; Georg D
    Radiother Oncol; 2011 Feb; 98(2):154-61. PubMed ID: 21176984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma.
    Vees H; Casanova N; Zilli T; Imperiano H; Ratib O; Popowski Y; Wang H; Zaidi H; Miralbell R
    Radiat Oncol; 2012 Oct; 7():176. PubMed ID: 23088346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
    Vesprini D; Ung Y; Dinniwell R; Breen S; Cheung F; Grabarz D; Kamra J; Mah K; Mansouri A; Pond G; Brock K; Darling G; Knox J; Haider M; Wong RK
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):631-8. PubMed ID: 18755578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.
    Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp LJ; Comans EF; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Nowak PJ; van Herk M; Rasch CR
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):435-48. PubMed ID: 16198064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma.
    Bird D; Scarsbrook AF; Sykes J; Ramasamy S; Subesinghe M; Carey B; Wilson DJ; Roberts N; McDermott G; Karakaya E; Bayman E; Sen M; Speight R; Prestwich RJ
    BMC Cancer; 2015 Nov; 15():844. PubMed ID: 26530182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver variation in clinical target volume (CTV) delineation for stereotactic radiotherapy to non-spinal bone metastases in prostate cancer: CT, MRI and PET/CT fusion.
    Chapman ER; Nicholls L; Suh YE; Khoo V; Levine D; Ap Dafydd D; Van As N
    Radiother Oncol; 2023 Mar; 180():109461. PubMed ID: 36634852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide study.
    Nowee ME; Voncken FEM; Kotte ANTJ; Goense L; van Rossum PSN; van Lier ALHMW; Heijmink SW; Aleman BMP; Nijkamp J; Meijer GJ; Lips IM;
    Clin Transl Radiat Oncol; 2019 Jan; 14():33-39. PubMed ID: 30519647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DE-MR simulation imaging for prone radiotherapy after breast-conserving surgery: assessing its application in lumpectomy cavity delineation based on deformable image registration.
    Zhao C; Li J; Wang W; Gong G; Xu L; Zhang Y; Li F; Shao Q; Wang J; Liu X; Xu M
    Radiat Oncol; 2021 May; 16(1):91. PubMed ID: 34001182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-observer agreement in GTV delineation of bone metastases on CT and impact of MR imaging: A multicenter study.
    Gerlich AS; van der Velden JM; Kotte ANTJ; Tseng CL; Fanetti G; Eppinga WSC; Kasperts N; Intven MPW; Pameijer FA; Philippens MEP; Verkooijen HM; Seravalli E
    Radiother Oncol; 2018 Mar; 126(3):534-540. PubMed ID: 28919003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of integrated PET/CT on variability of target volume delineation in rectal cancer.
    Patel DA; Chang ST; Goodman KA; Quon A; Thorndyke B; Gambhir SS; McMillan A; Loo BW; Koong AC
    Technol Cancer Res Treat; 2007 Feb; 6(1):31-6. PubMed ID: 17241098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of clip markers placed by endoscopic ultrasonography in contouring gross tumor volume for thoracic esophageal squamous cell carcinoma: one prospective study.
    Guan Y; Wang J; Cao F; Chen X; Wang Y; Jiang S; Zhang D; Zhang W; Guo Z; Wang P; Pang Q
    Ann Transl Med; 2020 Sep; 8(18):1144. PubMed ID: 33240993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of rigid and deformable image registration for nasopharyngeal carcinoma radiotherapy planning with diagnostic position PET/CT.
    Kai Y; Arimura H; Toya R; Saito T; Matsuyama T; Fukugawa Y; Shiraishi S; Shimohigashi Y; Maruyama M; Oya N
    Jpn J Radiol; 2020 Mar; 38(3):256-264. PubMed ID: 31834577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-observer and intra-observer reliability for lung cancer target volume delineation in the 4D-CT era.
    Louie AV; Rodrigues G; Olsthoorn J; Palma D; Yu E; Yaremko B; Ahmad B; Aivas I; Gaede S
    Radiother Oncol; 2010 May; 95(2):166-71. PubMed ID: 20122749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer.
    Muijs CT; Beukema JC; Pruim J; Mul VE; Groen H; Plukker JT; Langendijk JA
    Radiother Oncol; 2010 Nov; 97(2):165-71. PubMed ID: 20541273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers.
    Breen SL; Publicover J; De Silva S; Pond G; Brock K; O'Sullivan B; Cummings B; Dawson L; Keller A; Kim J; Ringash J; Yu E; Hendler A; Waldron J
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):763-70. PubMed ID: 17379435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?
    Walter F; Jell C; Zollner B; Andrae C; Gerum S; Ilhan H; Belka C; Niyazi M; Roeder F
    Strahlenther Onkol; 2021 Sep; 197(9):780-790. PubMed ID: 33104815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
    Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study.
    Gurney-Champion OJ; Versteijne E; van der Horst A; Lens E; Rütten H; Heerkens HD; Paardekooper GMRM; Berbee M; Rasch CRN; Stoker J; Engelbrecht MRW; van Herk M; Nederveen AJ; Klaassen R; van Laarhoven HWM; van Tienhoven G; Bel A
    Acta Oncol; 2017 Jul; 56(7):923-930. PubMed ID: 28375667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.